Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.368
Peer-review started: February 3, 2023
First decision: March 15, 2023
Revised: March 23, 2023
Accepted: April 21, 2023
Article in press: April 21, 2023
Published online: May 16, 2023
Processing time: 101 Days and 20.3 Hours
Rectal neuroendocrine tumours represent a rare colorectal tumour with a 10 fold increased prevalence due to incidental detection in the era of colorectal screening. Patient outcomes with early diagnosis are excellent. However endoscopic recognition of this lesion is variable and misdiagnosis can result in suboptimal endoscopic resection with subsequent uncertainty in relation to optimal long-term management. Endoscopic techniques have shown particular utility in managing this under-recognized neuroendocrine tumour.
Core Tip: Rectal neuroendocrine tumours (r-NETs) are increasingly detected during colorectal screening. Endoscopists may not accurately distinguish r-NETs from other polyps and inadvertent resection attempts result in significant post resection challenges. r-NETs have an unpredictable metastasis pattern, requiring appropriate pre-resection assessment. Accurate endoscopic assessment and resection provides an effective option in the management of r-NETs.